Does Farxiga Cause Weight Loss?
Yes, Farxiga (dapagliflozin), an SGLT2 inhibitor for type 2 diabetes, heart failure, and chronic kidney disease, causes modest weight loss in many patients. Clinical trials show average reductions of 2-3 kg (4-7 lbs) over 6-12 months, mainly from calorie loss via glucose excretion in urine.[1][2] This effect persists with long-term use but varies by dose (5-10 mg daily), diet, and baseline weight.
How Much Weight Loss Can Patients Expect?
In pivotal trials like DECLARE-TIMI 58 (17,000+ patients), those on 10 mg Farxiga lost about 2.9 kg at 4 years, compared to minimal change on placebo.[1] Real-world data from studies like DAPA-CKD report similar 2-3 kg drops, sustained up to 2.5 years.[3] Women and those with higher BMI often see slightly more loss.
Why Does Farxiga Lead to Weight Loss?
It blocks sodium-glucose cotransporter 2 in kidneys, increasing urinary glucose excretion (50-100 g/day), which equals 200-400 calories lost daily without reducing food intake.[2] About two-thirds of the loss is fat mass; the rest is fluid initially. Unlike GLP-1 drugs, it doesn't suppress appetite directly.
How Does Farxiga's Weight Loss Compare to Other Diabetes Drugs?
Farxiga outperforms metformin (0-1 kg loss) and sulfonylureas (1-2 kg gain) but trails GLP-1 agonists like Ozempic (5-15 kg loss) or dual agents like Mounjaro (15-20+ kg).[4] Versus rivals like Jardiance (empagliflozin), losses are nearly identical (2-4 kg).[1]
| Drug | Avg. Weight Loss (1 Year) | Mechanism |
|------|---------------------------|-----------|
| Farxiga | 2-3 kg | Caloric loss via urine |
| Jardiance | 2-4 kg | Same (SGLT2) |
| Ozempic | 5-10 kg | Appetite suppression |
| Metformin | 0-1 kg | Mild GI effects |
Who Experiences Weight Loss on Farxiga?
Most adults with type 2 diabetes (80-90% in trials) lose weight, especially if obese (BMI >30).[1] Less common in heart failure patients without diabetes, where loss averages 1-2 kg.[3] Not approved for weight loss alone; FDA labels note it as a secondary benefit.
What Side Effects Offset the Weight Loss?
Dehydration risk from fluid loss can mimic more weight drop initially (1-2 kg water weight).[2] Other effects include genital infections (5-10%), UTIs (4-6%), and rare ketoacidosis. Weight loss plateaus after 6 months for many; rebound gain possible if stopped.
Can Farxiga Be Used Off-Label for Weight Loss?
No FDA approval for obesity; trials exclude non-diabetics. Some doctors prescribe for overweight diabetics, but guidelines prioritize glucose/heart benefits. Alternatives like Wegovy target weight primarily.
[1]: FDA Farxiga Label
[2]: NEJM DECLARE-TIMI 58 Trial
[3]: DAPA-CKD Trial Lancet
[4]: ADA Standards of Care 2024